Hydrogen Gas Shows Promise as Therapy for Respiratory Diseases

TL;DR

Scientists found that tiny gas molecules our bodies naturally make—like nitric oxide and hydrogen sulfide—can help doctors diagnose lung diseases like asthma and COVID-19, and these gases might even be used as treatments to help sick lungs heal. This matters because it could give doctors a whole new way to fight serious breathing problems.

Key Finding

Gasotransmitters including hydrogen gas show promise as both biomarkers for diagnosing and monitoring respiratory diseases and as therapeutic agents, with recent advances in drug delivery methods enhancing their potential clinical applications.

Summary

This review article examines gasotransmitters—small gas molecules naturally produced by the body that have specific biological roles—and their potential in treating respiratory diseases like asthma, COPD, and lung infections. The article discusses how gasotransmitters such as hydrogen gas, nitric oxide, carbon monoxide, and hydrogen sulfide can be measured in exhaled breath to help diagnose diseases and track their severity, and how new drug formulations are being developed to harness their protective effects on cells.

Practical Takeaway

While this is a review article rather than original research, it suggests that hydrogen gas and other gasotransmitters may have future therapeutic roles in respiratory disease management. However, this is an early-stage overview of the field, and substantial additional research is needed before any clinical applications can be established for hydrogen-based treatments in humans.

Abstract (excerpt)

Significance: Gasotransmitters are small gas molecules that are endogenously generated and have well-defined physiological functions. The most well-defined gasotransmitters currently are nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide (H 2 S), while other potent gasotransmitters…

Read the full abstract via DOI